Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 517 results found. Search for [ US FDA ]

Results 1 to 21 of 517
BusinessToday.In
New Delhi, February 15, 2019
Reacting to the news, shares of the pharma major declined as much as 22 per cent amid heavy volume to touch an intra-day low of Rs 2,065.30 apiece on the BSE, after opening lower at Rs 2650.10 against previous closing price of 2669.30.


PTI
February 15, 2019



BusinessToday.In
February 11, 2019
The Dr Reddy's Laboratories share opened at a loss of 3.69% at 2,670 today compared to the previous close of 2,772.30 on the BSE. The Dr Reddy's Laboratories stock further crashed 216 points or 7.81% to 2555.5 level on the BSE.


PTI
February 6, 2019



PTI
February 6, 2019



PTI
January 29, 2019



BusinessToday.In
January 28, 2019
The large cap stock fell up to 4.70%  to 746.70 level compared to the previous close of 783.40 on the BSE.  It closed 3% or 23.50 points lower at 759.90 level on BSE.


BusinessToday.In
January 28, 2019
The large cap stock fell 2.09% to 845 level in trade today compared to the previous close of 863 level on the BSE. The stock has lost 9.01% during the last one year.


PTI
January 27, 2019



PTI
January 26, 2019



PTI
January 21, 2019



PTI
January 8, 2019



PTI
January 7, 2019



PTI
January 4, 2019



BusinessToday.In
New Delhi, January 3, 2019
Extending its gaining streak, shares of the pharma company surged as much as 17.58 per cent and touched 52-week high of Rs 694.20 apiece on BSE.


PTI
December 31, 2018



E Kumar Sharma
New Delhi, December 27, 2018
J&J vehemently denies any wrong doing, calls its product absolutely safe.


Dr K Ravindranath
New Delhi, December 25, 2018
\"Failing organs and tissues can be revived or replaced with the help of lab-grown and 3D-printed substitutes,\" says Dr K Ravindranath, Founder and Chairman, Gleneagles Global Hospitals Group.


PTI
December 21, 2018



PB Jayakumar
December 19, 2018
Ogivri (Trastuzumab), jointly developed by Biocon and Mylan, is the biosimilar version of Swiss drug maker Roche's Herceptin.


PAGES 1 OF 26  12345